Ronald P DeMatteo Selected Research

Necrosis

9/2012	Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome.
10/2008	Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronald P DeMatteo Research Topics

Disease

110	Neoplasms (Cancer) 04/2022 - 01/2002
44	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2003
36	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2022 - 11/2002
18	Colorectal Neoplasms (Colorectal Cancer) 06/2019 - 02/2007
9	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 11/2002
8	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 11/2012
7	Adenocarcinoma 12/2020 - 03/2006
6	Cholangiocarcinoma 01/2020 - 08/2014
6	Margins of Excision 01/2017 - 02/2008
5	Carcinoma (Carcinomatosis) 01/2018 - 03/2002
5	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017 - 01/2012
5	Liver Failure 10/2017 - 10/2014
4	Inflammation (Inflammations) 01/2020 - 02/2010
4	Infections 12/2014 - 04/2007
3	Pancreatic Cyst 01/2018 - 01/2011
3	Jaundice (Icterus) 09/2017 - 03/2004
3	Fibrosis (Cirrhosis) 05/2017 - 03/2006
3	Neoplasms, Cystic, Mucinous, and Serous 12/2015 - 10/2012
3	Reperfusion Injury 10/2012 - 02/2010
3	Ischemia 10/2012 - 02/2010
3	Gallbladder Neoplasms (Gallbladder Cancer) 08/2011 - 03/2002
3	Peritonitis 05/2011 - 06/2008
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2016
2	COVID-19 01/2021 - 01/2021
2	Hyperbilirubinemia 05/2020 - 02/2014
2	Rectal Neoplasms (Rectal Cancer) 10/2019 - 06/2015
2	Hypophosphatemia 02/2019 - 10/2017
2	Lymphatic Metastasis 09/2018 - 01/2012
2	Cholangitis 09/2018 - 09/2017
2	Autoimmune Pancreatitis 01/2018 - 11/2011
2	Pancreatic Intraductal Neoplasms 01/2018 - 01/2011
2	Hepatitis 12/2017 - 03/2006
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2017 - 05/2014
2	Klatskin Tumor 12/2015 - 03/2002
2	Carcinogenesis 12/2015 - 09/2012
2	Liver Diseases (Liver Disease) 11/2015 - 11/2002
2	Diabetes Mellitus 11/2015 - 01/2013
2	Hypoxia (Hypoxemia) 01/2015 - 08/2011
2	Abscess 05/2014 - 11/2007
2	Fatty Liver 01/2013 - 12/2003
2	Necrosis 09/2012 - 10/2008
2	Sepsis (Septicemia) 03/2011 - 06/2008

Drug/Important Bio-Agent (IBA)

24	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 11/2002
7	Biomarkers (Surrogate Marker)IBA 06/2019 - 01/2012
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2006
6	Tyrosine Kinase InhibitorsIBA 01/2021 - 03/2007
6	AntigensIBA 04/2018 - 06/2003
5	Biological ProductsIBA 04/2022 - 01/2014
5	Carcinoembryonic AntigenIBA 01/2018 - 02/2009
5	CytokinesIBA 10/2012 - 11/2006
4	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2013
4	Phosphotransferases (Kinase)IBA 01/2019 - 08/2007
4	BilirubinIBA 09/2017 - 08/2009
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 12/2013
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 12/2011
3	Floxuridine (FUdR)FDA LinkGeneric 01/2020 - 08/2011
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 10/2012
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019 - 11/2012
3	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2016
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2017 - 03/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 05/2009
3	Bevacizumab (Avastin)FDA Link 02/2015 - 08/2011
3	Hemoglobins (Hemoglobin)IBA 12/2013 - 12/2009
3	MucinsIBA 10/2012 - 01/2011
2	Gemcitabine FDA Link 01/2020 - 07/2014
2	Phosphates (Orthophosphate)IBA 02/2019 - 10/2017
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2017
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2018 - 03/2004
2	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 01/2017
2	Immunoglobulin G (IgG)IBA 01/2018 - 11/2011
2	CateninsIBA 12/2017 - 01/2017
2	Fetal Proteins (Fetoprotein)IBA 12/2017 - 05/2017
2	LigandsIBA 01/2017 - 07/2012
2	pasireotideIBA 01/2017 - 05/2014
2	Messenger RNA (mRNA)IBA 01/2017 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 08/2011
2	Oncogene Proteins (Oncogene Protein)IBA 12/2013 - 08/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2013 - 12/2011
2	Interleukin-10 (Interleukin 10)IBA 03/2011 - 02/2010

Therapy/Procedure

38	Therapeutics 01/2022 - 11/2002
30	Hepatectomy 01/2018 - 01/2002
28	Drug Therapy (Chemotherapy) 01/2021 - 11/2003
9	Length of Stay 12/2021 - 03/2002
7	Pancreatectomy 12/2020 - 04/2004
6	Immunotherapy 01/2020 - 09/2002
6	Transplantation 01/2018 - 11/2002
5	Pancreaticoduodenectomy 01/2022 - 08/2013
5	Neoadjuvant Therapy 01/2021 - 08/2013
5	Laparotomy 09/2018 - 03/2002
4	Cholecystectomy 03/2015 - 03/2002
3	Operative Surgical Procedures 01/2021 - 09/2003
3	Radiotherapy 10/2019 - 10/2003
3	Liver Transplantation 01/2018 - 10/2011
3	Salvage Therapy 08/2015 - 08/2007
2	Ligation 01/2018 - 06/2008
2	Operative Time 01/2016 - 01/2013
2	Radiofrequency Ablation 12/2014 - 11/2007
2	Stents 02/2014 - 01/2014
2	Molecular Targeted Therapy 01/2011 - 11/2002